CIK: 1752827 - Address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham, MA 02451
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/20/24 16:05
2/16/24
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsMartin Daniel C.MAOChief CoS.d-3515.620-2-455D
1/18/24 16:15
1/16/24
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsMartin Daniel C.MAOChief CoS-2314.470-2-348D
12/14/23 16:05
12/13/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsMartin Daniel C.MAOChief CoS-2715.370-2-349D
12/1/23 16:05
11/30/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsMartin Daniel C.MAOChief CoS-22412.570-18-2845D
10/31/23 16:10
10/30/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsMartin Daniel C.MAOChief CoS-1712.020-1-263D
6/21/23 16:05
6/16/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsMartin Daniel C.MAOChief CoS-1814.400-1-258D
2/17/23 16:12
2/16/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsMartin Daniel C.MAOChief CoS.d-1815.100-1-258D
1/19/23 16:05
1/17/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsMartin Daniel C.MAOChief CoS-3421.240-2-348D
6/21/22 16:35
6/16/22
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsMartin Daniel C.MAOChief CoS-1410.750-1-350D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact